{"id":"https://openalex.org/W45938194","doi":null,"title":"A study on the effect and tolerance of lisuride on Parkinson's disease.","display_name":"A study on the effect and tolerance of lisuride on Parkinson's disease.","publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W45938194","mag":"45938194","pmid":"https://pubmed.ncbi.nlm.nih.gov/8615174"},"language":"en","primary_location":{"id":"pmid:8615174","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8615174","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in neurology","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000267452","display_name":"Kemal Bay\u00fclkem","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108009","display_name":"Haseki E\u011fitim ve Ara\u015ft\u0131rma Hastanesi","ror":"https://ror.org/010q6ek40","country_code":"TR","type":"healthcare","lineage":["https://openalex.org/I4210108009"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"K Bay\u00fclkem","raw_affiliation_strings":["Department of Neurology, Haseki Hospital, Ministry of Health, Istanbul, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Haseki Hospital, Ministry of Health, Istanbul, Turkey","institution_ids":["https://openalex.org/I4210108009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008663559","display_name":"K Eri\u015fir","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Eri\u015fir","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"A Tuncel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Tuncel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004517972","display_name":"B. Bay\u00fclkem","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Bay\u00fclkem","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5573,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.64346096,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"69","issue":null,"first_page":"519","last_page":"30"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10863","display_name":"Voice and Speech Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3616","display_name":"Speech and Hearing"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lisuride","display_name":"lisuride","score":1.0},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.996999979019165},{"id":"https://openalex.org/keywords/l-dopa","display_name":"L-DOPA","score":0.8759999871253967},{"id":"https://openalex.org/keywords/benserazide","display_name":"benserazide","score":0.996999979019165},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6179999709129333},{"id":"https://openalex.org/keywords/drug-tolerance","display_name":"drug tolerance","score":0.609000027179718},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.722000002861023},{"id":"https://openalex.org/keywords/xerostomia","display_name":"xerostomia","score":0.8140000104904175},{"id":"https://openalex.org/keywords/orthostatic-hypotension","display_name":"orthostatic hypotension","score":0.8450000286102295},{"id":"https://openalex.org/keywords/motor-fluctuations","display_name":"motor fluctuations","score":0.6240000128746033},{"id":"https://openalex.org/keywords/off-periods","display_name":"off periods","score":0.5429999828338623},{"id":"https://openalex.org/keywords/disability-score","display_name":"disability score","score":0.5130000114440918},{"id":"https://openalex.org/keywords/activities-of-daily-living","display_name":"activities of daily living","score":0.9929999709129333}],"concepts":[{"id":"https://openalex.org/C2777095659","wikidata":"https://www.wikidata.org/wiki/Q424446","display_name":"Lisuride","level":5,"score":0.9961786866188049},{"id":"https://openalex.org/C2779026782","wikidata":"https://www.wikidata.org/wiki/Q818165","display_name":"Benserazide","level":5,"score":0.9116377234458923},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.820772111415863},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5968487858772278},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5324633717536926},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.513871431350708},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.5082330703735352},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.5009491443634033},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32548245787620544},{"id":"https://openalex.org/C2778258207","wikidata":"https://www.wikidata.org/wiki/Q600203","display_name":"Dopamine agonist","level":4,"score":0.19461700320243835},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.16380199790000916},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.1151648461818695},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.09167829155921936}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001545","descriptor_name":"Benserazide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008090","descriptor_name":"Lisuride","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008090","descriptor_name":"Lisuride","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008090","descriptor_name":"Lisuride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D011388","descriptor_name":"Prolactin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017668","descriptor_name":"Age of Onset","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:8615174","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8615174","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in neurology","raw_type":"Clinical Trial"},{"id":"mag:45938194","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8615174","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1988692937","https://openalex.org/W1971677454","https://openalex.org/W2048713536","https://openalex.org/W2052170949","https://openalex.org/W2017768602","https://openalex.org/W2460291686","https://openalex.org/W2397394406","https://openalex.org/W2143393134","https://openalex.org/W2074583433","https://openalex.org/W2087502903"],"abstract_inverted_index":{"Seventeen":[0],"idiopathic":[1],"parkinsonian":[2],"patients":[3,53],"ranging":[4],"between":[5,84],"47":[6],"and":[7,21,49,86,126,138,163,197],"75":[8],"years":[9],"of":[10,23,29,97,110,147,169,174,187],"age":[11],"were":[12,140],"included":[13],"in":[14,46,51,54,58,108,118,123,128,130,153,166,208],"this":[15,30],"study":[16],"to":[17,68,79,99,120,184],"investigate":[18],"the":[19,55,59,95,101,141,167,172,185,188],"effect":[20],"tolerance":[22],"lisuride":[24,66,76,98,116,170],"on":[25,159],"PD.":[26],"The":[27],"duration":[28],"simple":[31],"clinical":[32],"study,":[33],"which":[34],"had":[35],"no":[36],"control":[37],"group":[38,57],"was":[39,43,106],"12":[40,63],"weeks.":[41],"There":[42],"50%":[44],"relief":[45,129],"disability":[47,124],"scores":[48,125],"ADL":[50],"13":[52,111],"first":[56],"combined":[60,181],"therapy":[61,182],"for":[62],"weeks":[64],"with":[65,115],"added":[67,78],"L-DOPA":[69,80,102],"plus":[70,81,103],"benserazide":[71,82,104],"(p":[72],"<":[73],"0.01).":[74],"Optimal":[75],"doses":[77],"varied":[83],"0.1":[85],"0.8":[87],"mg":[88],"(mean":[89],"0.5":[90],"+/-":[91],"0.2":[92],"mg).":[93],"With":[94],"addition":[96],"treatment,":[100],"dose":[105,168],"reduced":[107],"6":[109],"by":[112],"38%.":[113],"Monotherapy":[114],"resulted":[117],"56%":[119],"57%":[121],"improvement":[122],"47%":[127],"ADL.":[131],"Dry":[132],"mouth,":[133],"nausea,":[134],"weakness,":[135],"postural":[136],"hypotension,":[137],"headache":[139],"most":[142],"frequently":[143],"encountered":[144],"side":[145],"effects":[146,151],"lisuride.":[148],"These":[149],"adverse":[150],"disappeared":[152],"3":[154],"or":[155,211],"4":[156],"days,":[157],"depending":[158],"a":[160,180,205],"slight":[161],"decrease":[162],"following":[164],"increase":[165],"and/or":[171],"development":[173],"tolerance.":[175],"Not":[176],"only":[177],"will":[178],"such":[179],"contribute":[183],"reduction":[186],"end-of-dose":[189],"inadequacies,":[190],"on-off":[191],"phenomena,":[192],"wearing":[193],"off,":[194],"peak-dose":[195],"dyskinesias,":[196],"similar":[198],"motor":[199],"fluctuations,":[200],"it":[201],"may":[202],"also":[203],"play":[204],"prophylactic":[206],"role":[207],"their":[209],"prevention":[210],"delay.":[212]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}